Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Matrix ; 9(2): 150-8, 1989 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-2725421

RESUMO

Conditioned media of Kupffer cells from normal rat liver produce in culture two factors that inhibit fibroblast proliferation. The inhibitory factors have molecular masses of approximately 25 and 5 kDa. In contrasts to these results, the conditioned media of Kupffer and mononuclear macrophagic cells, obtained 48 hours after CC1(4) administration to rats, contains a 17 kDa factor that stimulates fibroblast proliferation (FSF). FSF also stimulates [3H]-thymidine incorporation into DNA of cultured rat liver fat-storing cells. Two peaks with FSF activity were demonstrated after isoelectrofocusing; one with a pI of 6.1 and a second with a pI of 7.5. The fraction containing FSF is devoid of interleukin-1 (IL-1) activity and no inhibitory activity is detected in this conditioned media. Production of FSF is inhibitable by colchicine but not by indomethacin, it is thermolabile and trypsin-sensitive. In animals treated chronically with CC1(4) to produce cirrhosis, FSF activity is demonstrable from the first to the 8th week of treatment. However, the activity is lower at 8 weeks post-CC1(4) as compared with 2 weeks. The results suggest that homeostasis of cells in the liver is controlled by factors produced locally, that act by autocrine and paracrine mechanisms. When homeostasis is altered, fibroblast proliferation occurs, and excess collagen deposition leads to fibrosis. We propose that the antifibrogenic activity of colchicine is associated, in part, with its capacity to inhibit the release of FSF by Kupffer cells and liver mononuclear macrophage cells.


Assuntos
Tetracloreto de Carbono/farmacologia , Fibroblastos/citologia , Substâncias de Crescimento/metabolismo , Células de Kupffer/metabolismo , Metabolismo dos Lipídeos , Fígado/citologia , Animais , Divisão Celular/efeitos dos fármacos , Células Cultivadas , Fibroblastos/efeitos dos fármacos , Células de Kupffer/efeitos dos fármacos , Fígado/efeitos dos fármacos , Fígado/metabolismo , Masculino , Peso Molecular , Ratos
2.
J Histochem Cytochem ; 36(12): 1471-4, 1988 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-2461410

RESUMO

We describe a simple, sensitive, and quantitative procedure for measurement of triglycerides and protein contents in formalin-fixed liver sections. The method can detect as little as 0.27 microgram of triglycerides per mg of protein. It is based on selective binding of Sudan IV and Fast Green FCF to fat and total proteins, respectively, and their sequential elution with solvents. Sudan IV is eluted readily with acetone and Fast Green with NaOH-methanol, and the absorbances obtained at 500 and 610 nm can be used to determine the amount of triglycerides and total protein. The color equivalence for Fast Green was obtained after destaining the sections and measuring the protein contents by micro-Kjeldahl analysis. The color equivalence of Sudan IV was estimated by determining the triglyceride content in liver homogenates by an enzymatic procedure and then measuring the amount of dye bound to multiple fixed sections. There was a strong linear correlation between the triglyceride content as determined chemically and that obtained using the equivalence colors (r2 = 0.98). This method is useful to measure fat content in tissue samples and could be applied to evaluate the progression of liver disease.


Assuntos
Formaldeído , Lipídeos/análise , Fígado/análise , Animais , Compostos Azo , Tetracloreto de Carbono/toxicidade , Doença Hepática Induzida por Substâncias e Drogas , Fixadores , Histocitoquímica , Corantes Verde de Lissamina , Hepatopatias/metabolismo , Proteínas/análise , Ratos , Coloração e Rotulagem , Triglicerídeos/análise
3.
N Engl J Med ; 318(26): 1709-13, 1988 Jun 30.
Artigo em Inglês | MEDLINE | ID: mdl-3287167

RESUMO

There is preliminary evidence that colchicine, an inhibitor of collagen synthesis, may be beneficial in the treatment of cirrhosis of the liver. To evaluate the use of colchicine (1 mg per day, five days per week) in the treatment of hepatic cirrhosis, we performed a randomized, double-blind, placebo-controlled trial in which 100 patients were followed for up to 14 years. Forty-five patients had alcoholic cirrhosis, 41 had posthepatitic cirrhosis, and the remaining 14 had cirrhosis with various other causes. Histologic studies were available for 92 percent of patients. Seventy-three patients were in Child-Turcotte class A, 26 were in class B, and one was in class C. Fifty-four patients received colchicine, and 46 received placebo. The overall survival in the colchicine group was markedly better than in the placebo group (median survival, 11 and 3.5 years, respectively; P less than 0.001). The cumulative 5-year survival rates were 75 percent in the colchicine group and 34 percent in the placebo group; the corresponding 10-year survival rates were 56 percent and 20 percent. Among the 30 patients treated with colchicine who underwent repeated liver biopsies, histologic improvement was seen in 9; the liver appeared normal in 2, and 7 had minimal portal fibrosis. No histologic improvement was observed in the 14 members of the placebo group who had two or more biopsies. Few side effects were observed in either group.


Assuntos
Colchicina/uso terapêutico , Cirrose Hepática/tratamento farmacológico , Ensaios Clínicos como Assunto , Colchicina/administração & dosagem , Colchicina/efeitos adversos , Método Duplo-Cego , Feminino , Seguimentos , Hepatite/complicações , Humanos , Cirrose Hepática/mortalidade , Cirrose Hepática Alcoólica/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Distribuição Aleatória
7.
Rev. invest. clín ; Rev. invest. clín;34(1): 1-6, 1982.
Artigo em Espanhol | LILACS | ID: lil-10449

RESUMO

Se diseno y aplico cuestionario autoadministrable de alcoholismo (CUAAL) a 121 enfermos alcoholicos de um centro especializado, a 150 enfermos con diversos problemas medicos y quirurgicos del Instituto Nacional de la Nutricion (INN) y a 43 controles sanos. Los 121 pacientes del primer grupo (100%) y 26 pacientes del INN (17.3%) fueron clasificados como alcoholicos en base a los criterios del Consejo Nacional de Alcoholismo de los Estados Unidos. De estos, 132 contestaron el cuestionario en forma antodministrada alcanzando un puntaje de 21.0 +/- 5.5. En contraste, 108 pacientes no alcoholicos (todos del INN) obtuvieron una calificacion de 3.0 +/- 2.5 y los 43 controles de 2.0 +/- 1.2. Las diferencias entre el grupo de alcoholicos y los grupos de no alcoholicos resultaron estadisticamente significativas (p <0,001). El esto de los pacientes (15 alcoholicos y 16 no alcoholicos) contestaron el cuestionario en forma de entrevista por ser analfabetas, con resultados similares. La sensibilidad calculada para la prueba fue de 95%, la especificidad de 96% Los autores concluyen que el CUAAL puede ser un instrumento util que auxilie al clinico en el diagnostico precoz del alcoholismo


Assuntos
Humanos , Alcoolismo , Inquéritos e Questionários
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA